Clinical Trial Update: Evaluate Safety and Efficacy of Apitox Add-on Therapy for Improving Disability and Quality of Life in MS Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety and efficacy of Apitox as an add-on therapy to improve disability and quality of life in multiple sclerosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Apitox (honeybee venom)

Snippet

Sponsor: Apimeds, Inc. | Conditions: Multiple Sclerosis | Phase 3 | Status: UNKNOWN